Could cause temporary or reversible harm; serious harm is unlikely.
Defective container - seal not adhering to bottles
| Brand name | SERTRALINE HYDROCHLORIDE |
| Generic name | SERTRALINE HYDROCHLORIDE |
| Active ingredient(s) | SERTRALINE HYDROCHLORIDE |
| Distributed by / for | Lupin Pharmaceuticals Inc. |
| NDC | 68180-353-09 |
| Full product label | Sertraline Hydrochloride Tablets USP, 100 mg, 90 Tablets bottles, Rx Only, Manufactured by: Lupin Pharmaceuticals, Inc., Naples, FL 34108, NDC 68180-353-09. |
| Recalling firm | Lupin Pharmaceuticals Inc. |
| Distribution | Nationwide. |
| Quantity | 52,128 bottles |
| Recall initiated | 2025-11-05 |
| Report date | 2025-12-17 |
| Recall completed | — |
| Recall number | D-0227-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Naples FL United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗